⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ENTX News
Entera Bio Ltd. Ordinary Shares
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
globenewswire.com
ENTX
OPK
Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook
globenewswire.com
ENTX
Oral Protein and Peptides Market to Hit Valuation of US$ 47.33 Billion By 2035 | Astute Analytica
globenewswire.com
VKTX
LLY
NVO
MRK
FSK
TSN
KDP
PEP
MNDO
THG
ENTX
RANI
Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation
globenewswire.com
ENTX
Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)
globenewswire.com
ENTX
Entero's Grid AI Announces Major U.S. Expansion and Incoming Leadership to Accelerate AI Infrastructure Strategy
accessnewswire.com
AMD
ENTX
Osteoporosis Market Set to Expand Significantly During the Forecast Period (2025-2034) Due to Rising Aging Population and Novel Therapeutics | DelveInsight
prnewswire.com
AMGN
UCB
ENTX
RANI
ANGI
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
globenewswire.com
ENTX
Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates
globenewswire.com
ENTX
Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women
globenewswire.com
ENTX